News and events
The latest news from Cambridge Enterprise and information on events coming up in the coming months.
-
Cambridge spin-out CamGaN acquired by Plessey
CamGaN, a University spin-out in the area of high-brightness light-emitting diodes (HB-LEDs), has been acquired by Plessey, a semiconductor manufacturer based in Plymouth.
-
Creating star teams
The vital role of the team in creating successful ventures is the topic of the first Enterprise Tuesday session of the Lent Term, held this evening (7 February) in the Department of Engineering.
-
New form of hafnium oxide developed
A novel material developed by researchers at the University of Cambridge is opening up new possibilities for next generation electronic and optoelectronic devices, and paving the way for further component miniaturisation.
-
Under pressure
Technology developed at the University of Cambridge which facilitates electrical measurements under pressure is to be commercialised by easyLab, a Reading-based designer and manufacturer of equipment for high-pressure applications.
-
Lumora develops technique to improve speed and sensitivity of molecular diagnostics
A new technique for in vitro molecular diagnostics could provide increased speed, sensitivity and reproducibility over current methods, through the use of stem primers.
-
BlueGnome’s screening platform triples rate of embryo implantation in IVF
The screening platform developed by University of Cambridge spin-out BlueGnome triples rates of embryo implantation for women undergoing in vitro fertilisation (IVF) treatment, according to a recent study.
-
Eight19 launches new fund to bring affordable solar power to rural Africa
Cambridge spin-out company Eight19 has launched a new charitable fund which will help bring affordable solar lighting to rural off-grid communities in East Africa.
-
Enval secures funding for first commercial plant
University of Cambridge spin-out Enval has secured further funding for the commercialisation of its technology for the recycling of plastic-aluminium laminate packaging.
-
Cambridge partners with Lilly in Open Innovation Drug Discovery Platform
The University of Cambridge is partnering with global pharmaceutical company Eli Lilly and Company in an active collaboration programme helping to find and develop potential new medicines, particularly in the areas of greatest need.
-
Cambridge Enterprise announces 2011 results
Income generated from the University of Cambridge’s commercialisation activities continued to rise in 2011, as did the number of intellectual property, consultancy and equity agreements signed on behalf of the University and its researchers.